SA likely to miss herd immunity target in vaccination drive, says Prof Shabir Madhi

0:00
play article
Subscribers can listen to this article
Professor Shabir Madhi.
Professor Shabir Madhi.
Wits University
  • Vaccinology Professor Shabir Madhi says the country is unlikely to reach its herd immunity target.
  • Madhi said the local variant, and a third wave of infections expected later this year, were likely to hinder vaccination plans.
  • Government aims to vaccinate around 40 million people to achieve herd immunity by year's end.

The country is unlikely to reach its 2021 coronavirus herd immunity target and should "recalibrate" expectations around Covid-19 jabs, a top vaccinologist said on Monday.

A more transmissible coronavirus variant first identified in South Africa late last year fuelled the country's second infection wave and delayed the start of vaccinations in February.

Studies have shown the variant to be more resistant to most of the existing vaccines than the virus' original form and other mutations.

Vaccinology Professor Shabir Madhi, lead investigator on the Oxford/AstraZeneca vaccine trial in South Africa, said the local variant and a third wave of infections expected later this year were likely to hinder inoculation plans.

"We need to recalibrate... our understanding of what we can actually achieve with Covid-19 vaccines," Madhi told a virtual panel discussion.

"The notion of getting to herd immunity... at least with this first generation of Covid-19 vaccines, is extremely slim."

ALSO READ | Covid-19: First wave hit poorer communities hardest, likely to have improved herd immunity - report

Government aims to vaccinate 67% of its population - around 40 million people - to achieve herd immunity by year's end.

Inoculations started last month with jabs developed by US pharma giant Johnson & Johnson.

The rollout was briefly delayed after a study found that AstraZeneca vaccines - the first doses to land in the country - only offered limited protection against mild and moderate disease caused by the new variant.

Substantial quantities of the vaccines are only expected in April and May.

Infections are meanwhile expected to resurge in June or earlier if a cap on mass gatherings is lifted during the upcoming Easter holiday.

So far, South Africa has secured 11 million Johnson & Johnson vaccines and 20 million doses of a jab developed by Pfizer.

Another 12 million doses are expected from the WHO-backed vaccine pooling initiative Covax and an undetermined amount from the African Union.

The country is the worst-hit by the pandemic in Africa, with over 1.5 million cases and almost 50 000 deaths recorded to date.

But President Cyril Ramaphosa on Sunday said the start of vaccinations had, "... gone extremely well", and that daily infections had slowed enough to lift almost all movement restrictions.


Did you know you can comment on this article? Subscribe to News24 and add your voice to the conversation.
We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For only R75 per month, you have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today.
Subscribe to News24
Lockdown For
DAYS
HRS
MINS
Voting Booth
Would you choose to continue working from home after the coronavirus lockdown if given the option?
Please select an option Oops! Something went wrong, please try again later.
Results
Yes, it's much better for me
40% - 7015 votes
No ways! I can't wait to get back to the office
12% - 2047 votes
A mixture of both would suit me best
48% - 8433 votes
Vote
USD/ZAR
14.59
(+0.1)
GBP/ZAR
20.03
(-0.0)
EUR/ZAR
17.35
(-0.1)
AUD/ZAR
11.08
(-0.3)
JPY/ZAR
0.13
(-0.2)
Gold
1,731.85
(-0.1)
Silver
24.86
(+0.2)
Platinum
1,172.50
(-0.1)
Brent Crude
63.28
(+0.5)
Palladium
2,681.00
(+0.1)
All Share
66,390
(0.0)
Top 40
60,673
(0.0)
Financial 15
12,144
(0.0)
Industrial 25
86,617
(0.0)
Resource 10
67,175
(0.0)
All JSE data delayed by at least 15 minutes Iress logo